HEADLINES India News

Bharat Biotech starts phase III trials for Covaxin

Posted on Author ASNLIVE Comment(0)

Bharat Biotech has recently announced the commencement of phase III trials of the COVID-19 vaccine, Covaxin.

It will be the largest clinical trial conducted for a COVID-19 vaccine in India.

The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR.

Share
ASNLIVE

Related Articles
Defence HEADLINES News

DRDO’s new carbine clears Army’s final trials

Posted on Author ASNLIVE

Defence Research and Development Organisation (DRDO) has recently announce that a Carbine, jointly developed by its Pune-based facility and the Ordnance Factory Board (OFB), had completed its final phase of user trials by the Army and was ready for induction. The Joint Venture Protective Carbine (JVPC) is slated to replace the ageing 9 mm carbine […]
HEADLINES India News

Recovered cases more than active cases of Covid-19

Posted on Author ASNLIVE

The number of ‘recovered’ cases of Covid-19 has exceeded the number of ‘active’ cases on Wednesday for the first time in India. Around 5,991 patients were cured of Covid-19 in the last 24 hours. This takes the total number of patients recovered to 1,35,205. The total number of active cases in India is now 1,33,632 […]
HEADLINES India News

NGT directs CPCB to recover fine from Amazon, Flipkart

Posted on Author ASNLIVE

The National Green Tribunal has directed the Central Pollution Control Board (CPCB) to recover fine from Amazon and Flipkart for violation of environmental norms. The submission came in response to a plea filed by a 16-year-old boy who has approached the tribunal to stop e-commerce giants Amazon and Flipkart from using excessive plastic in their […]

Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea